Wendi Xuzhang

Shanghai Key Laboratory Of Thoracic Tumor Biotherapy
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002).

Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 10, 2026

Spatial multi-omics unveils the monoclonal origin, neuroendocrine plasticity, and microenvironment niches in combined small cell lung cancer.

Spatial multi-omics unveils the monoclonal origin, neuroendocrine plasticity, and microenvironment niches in combined small cell lung cancer.

Journal: bioRxiv : the preprint server for biology

Published: February 13, 2026

Spatial multi-omics unveils the monoclonal origin, neuroendocrine plasticity, and microenvironment niches in combined small-cell lung cancer.

Spatial multi-omics unveils the monoclonal origin, neuroendocrine plasticity, and microenvironment niches in combined small-cell lung cancer.

Journal: Cell reports. Medicine

Published: September 22, 2025

MYBL2 impedes cisplatin sensitivity through suppressing GSDME-mediated pyroptosis in lung adenocarcinoma.

MYBL2 impedes cisplatin sensitivity through suppressing GSDME-mediated pyroptosis in lung adenocarcinoma.

Journal: Cell death discovery

Published: September 14, 2025

BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancer.

BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancer.

Journal: Journal for immunotherapy of cancer

Published: April 18, 2025

The global burden of mesothelioma and its association with asbestos bans, 1990-2021: a population-based study.

The global burden of mesothelioma and its association with asbestos bans, 1990-2021: a population-based study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 09, 2024

Global cancer burdens related to human behaviors in 1990-2044: a population-based cross-sectional and forecast study.

Global cancer burdens related to human behaviors in 1990-2044: a population-based cross-sectional and forecast study.

Journal: Journal of the National Cancer Center

Published: January 01, 2024

Non-linear modifications enhance prediction of pathological response to pre-operative PD-1 blockade in lung cancer: A longitudinal hybrid radiological model.

Non-linear modifications enhance prediction of pathological response to pre-operative PD-1 blockade in lung cancer: A longitudinal hybrid radiological model.

Journal: Pharmacological research

Published: August 24, 2023

Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis.

Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis.

Journal: International journal of biological sciences

Published: August 12, 2023

Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC.

Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC.

Journal: Therapeutic advances in medical oncology

Published: June 01, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026